Skip to content

Consequences of Temporomandibular Disorder on Balance Control

Consequences of Temporomandibular Disorder on Balance Control

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03283839
Acronym
DAM
Enrollment
200
Registered
2017-09-14
Start date
2017-06-19
Completion date
2020-06-25
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Disorder, Pathophysiology, Therapy

Keywords

Temporo-mandibular dysfunction, Balance control, Orientation function

Brief summary

To evaluate the effects of the temporomandibular disorder (TMD) and its therapeutic care on postural control in somato-sensory and visual sensitization compared to control subjects matched on age, sex and lifestyle. Parameters will be estimated by measures realized before the therapeutic care of the TMD (T0), then 2, 3 and 5 months after the starting care, both in TMD patients and control subjects. To evaluate also the effects of the TMD and its therapeutic care on balance control in various contexts of multi-sensory stimulation, orientation function, pain and tinnitus.

Detailed description

Primary objective: to evaluate the effects of the temporomandibular disorder (TMD) and its therapeutic care on postural control in somato-sensory and visual sensitization compared to control subjects matched on age, sex and lifestyle.

Interventions

DIAGNOSTIC_TESTPosturography

Evaluation of postural control and of orientation function

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient group: TMD patients, care: occlusal splint therapy, behavioral advices * Control group: matched with TMD patients (age, sex, lifestyle).

Exclusion criteria

* Patient group: treatment generating secondary effects in postural control (psychotrop, antidepressor, antihypertensive drugs); osteoarticular pathologies and recent trauma (\< 4 months); vertigo and dysequilibrium (\< 6 months), whiplash * Control group: id. and TMD.

Design outcomes

Primary

MeasureTime frameDescription
Postural control (before care for patients)At inclusion (before care for patients) (first evaluation)Postural control is evaluate by the average of condition 5 and 6 of the sensory organisation test (SOT) measured on Equitest plateform.
Postural control (during care for patients)2 months after the first evaluationPostural control is evaluate by the average of condition 5 and 6 of the sensory organisation test (SOT) measured on Equitest plateform.

Secondary

MeasureTime frameDescription
Balance functionT0 and 2,3 and 5 months after the first evaluationLength and surface covered by the foot pressure center are measured
Orientation functionT0 and 2,3 and 5 months after the first evaluationOrientation is evaluated by the angle between the direction (of the gravity or of a part of his body) indicated by the subject and the real direction. It is evaluated with the road and frame test.
PainT0 and 2,3 and 5 months after the first evaluationVisual Analog Scale (1 to 10)
TinnitusT0 and 2,3 and 5 months after the first evaluationQuestionnaire

Countries

France

Contacts

Primary ContactPhilippe PERRIN
philippe.perrin@univ-lorraine.fr00 33 3 83 15 49 68
Backup ContactNathalie PAOLI
nathalie.paoli@univ-lorraine.fr00 33 3 83 15 49 68

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026